Novartis has entered a collaboration with Chai Discovery to advance the use of AI in the identification of therapeutic antibodies.

Cellares and Sonoma Biotherapeutics have partnered to automate the manufacturing of the latter’s SBT-77-7101 programme using the Cellares Cell Shuttle platform.

There are a range of cost-containment measures across the bill that will create a significant healthcare system shakeup.

The US Food and Drug Administration (FDA) has approved two of Merck & Co’s (MSD) Keytruda (pembrolizumab) and Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph), each combined with Padcev ...

Patient advocates in remission from MCL and FL discuss their treatment experiences with ASCT and CAR-T, while sharing views on latter's place in the treatment paradigm.